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Our ability to control both the cellular and humoral 
components of xenograft rejection in laboratory 
experiments, together with an organ shortage that 
has placed limits on clinical transplantation services, 
prompted us to undertake a liver transplantation from 
a baboon to a 35-year-old man with B virus-
associated chronic active hepatitis and human 
immunodeficiency virus infection. 
Liver replacement was performed according to 
conventional surgical techniques. Immuno-
suppression was with the FK 506-prednisone-
prostaglandin regimen used routinely for hepatic 
allotransplantation, to which a daily non-myelotoxic 
dose of cyclophosphamide was added. During 70 
days of survival, there was little evidence of hepatic 
rejection by biochemical monitoring or 
histopathological examination. Products of hepatic 
synthesis, including clotting factors, became those of 
the baboon liver with no obvious adverse effects. 
Death followed a cerebral and subarachnoid 
haemorrhage that was caused by an angioinvasive 
aspergillus infection. However, the underlying cause 
of death was widespread biliary sludge that formed 
in the biliary tree despite a seemingly satisfactory 
choledochojejunostomy. During life and in necropsy 
samples, there was evidence of the chimerism that 
we believe is integral to the acceptance of both 
xenografts and allografts. 
Our experience has shown the feasibility of 
controlling the rejection ofthe baboon liver xenograft 
in a human recipient. The biliary stasis that was the 
beginning of lethal infectious complications may be 
correctable by modifications of surgical technique. In 
further trials, the error of over-immunosuppression 
should be avoidable. 
Lancet 1993; 341 : 65-71. 
Introduction 
Previous attempts to transplant seven baboon kidneysl,z 
and two hearts3,4 resulted in graft loss or patient death 
between 0 and 60 days after transplantation. A oonunon 
difficulty was unoonttolled cellular rejection, together with 
antibody-mediated occlusive endothe1iolitis of graft 
miaovasculature and parenchymal neaosis.4.5 Recent 
laboratory investigations have shown that the preswnably 
hwnoral oomponent of xenograft rejection oould be 
diminished by a short course of antimetabolite therapy, such 
as cyclophosphamide, which targeted the B-cell 
proliferative response.6-& By overooming this antibody 
barrier, the value of maintenance therapy with T -cell-
directed immunosuppressants was unrnasked.6-3 
We now describe a baboon-to-human liver 
xenotransplantation in which FK 506 and 
cyclophosphamide were given as immunosuppressants, 
together with prednisone and prostaglandin, both of which 
help to mitigate preformed antigraft antibody syndromes 
and cellular rejection.9.10 
Patient and methods 
Recipient history 
A PR-year~ld white male had a history of abnonna1liver function 
tests since 1984 with recurrent bleeding from oesophageal varices 
and haemorrhoids which began 2 years later. Hepatitis 8 virus 
(HBV) and human immunodeficiency virus (HlV) had been 
diagnosed in 1987. When his spleen was ruptured and removed 
after a motorcycle accident in 1989, his prothrombin time cPT) was 
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TABLE I-DONOR AND RECIPIENT BIOCHEMISTRY 
Total 
Albumin protein 
-
(gIL) (gIL) 
Donor baboon 18 48 
Patient pl1'-<lp 20 63 
Patient 5 days post-op 20 52 
Paticnt 45 days post-op 19 40 
PT. prothrombin time 
15·7 s, aspartate aminotransferase (AST) lOS lUlL, alanine 
aminotransferase CAL T) 73 lUlL, albumin 2·7 giL, and total 
bilirubin 47·9 llffiollL. Macronodular cirrhosis of the liver was 
noted at the time of splenectomy, and a biopsy specimen confinned 
the clinical diagnosis of chronic active hepatitis. After being refused 
liver transplantation elsewhere, he came to Pittsburgh in January, 
1992, with jaundice, spider naevi, ascites, peripheral oedema, 
episodic encephalopathy, and deteriorating hepatic function. 
Hepatitis A, C, and delta were negative. Hepatitis B surface antigen 
(HBsAg) was positive and antibodies to hepatitis B core antigen 
were also present; e antigen was negative. There was serological 
evidence of previous infection with Epstein-Barr virus (EBV), 
cytomegalovirus (CMV), and herpes simplex virus (HSV). 
His clinical condition worsened between January and May, 1992, 
and he eventually required continuous hospital care. Because the 
baboon liver was thought to be resistant to HBV infection 
a. Hoofnagle, National Institutes of Health, personal 
conununication), baboon-to-human liver xenotransplantation for 
HBV hepatitis was already under discussion by the Institutional 
Review Board of the University of Pittsburgh and members of US 
government agencies. Although the HIV carrier state was an 
undesirable factor, the patient was accepted into the HBV 
xenotransplantation protocol because of his urgent clinical status. 
Prophylactic antiviral therapy with ganciclovir was started, but 
hyperimmune anti-B virus globulin was not given. 
Donor surveillance 
The 15-year-old male baboon (Papio cynocephalus), who had the 
same A blood group as the recipient, was obtained for organ 
donation from the Southwest Foundation for Research and 
Education, San Antonio, Texas. Retrovirus antibody screen 
revealed the animal to be negative for Simian T -lymphotropic 
virus, human T-cell leukaemia virus I and 2, Simian 
immunodeficiency virus, Simian retrovirus 1,2, and 5, and HIV 1 
and 2. He was antibody positive for foamy virus, and had evidence 
of previous infection with EBV, CMV, Simian agent 8, and 
Varicella-Zoster virus. Antibodies directed against herpes simplex 
virus and herpes B virus were not present. In addition, there was no 
evidence of infection with HBV, HAV, HCV, Marburg virus, 
encephalomyocarditis virus, lymphochoriomeningitis virus, and 
haemorrhagic fever virus. 
Donor biochemical tests that fell outside normal human ranges 
included alkaline phosphatase 387 IV /L, serum uric acid < 0·5 
mg/dL, serum cholesterol 1·03 mmol/L and serum albumin 18 gIL 
(table I). These values are normal for the baboon. 
Transplantation and postoperative course 
Uver replacement was done on June 28, 1992, by conventional 
techniques including venovenous bypass.'2 The 600 g liver from the 
25·8 kg baboon donor was preserved with University of Wisconsin 
solution for 137 min of cold ischaemia. It was inserted by the 
piggy-back technique into the 70 kg recipient whose excised liver 
weighed 1750 g. Xenograft venous outflow was through the 
transplant suprahepatic vena cava into a cuff of the left and middle 
veins of the excised native liver, which drained intO the intact 
retrohepatic inferior vena cava of the host. The xenograft coeliac 
axis and portal vein were anastomosed to the recipient conunon 
hepatic anery and left portal vein, respectively, after oversewing the 
right portal branch. Biliary reconstruction was with a roux-en-Y 
choledochojejunostomy. 20 units of blood were given during the 
11 h operation. Generalised wound bleeding secondary to pre-
existing coaguIopathy (PT 16·3 s) diminished substantially after the 
xenograft was revascuIarised. 
Alkaline 
Cholesterol PT phosphatase Uric acid 
(mmoI/L) (5) (lUlL) (Ilmol/ L) 
1'03 10·9 387 <30 
2·33 16·3 158 481·8 
H6 12'5 452 208·2 
1·71 11·5 2812 <30 
FK 506, prednisone, and prostaglandin are given routinely after 
liver allotransplantation (fig 1 ).13 Except for higher doses ofFK 506 
given during the first 2 postoperative weeks, the doses of all 3 drugs 
were within standard therapeutic ranges. In addition, non-
myelotoxic doses (25 to 175 mg/day) of cyclophosphamide were 
begun 2 days preoperatively and continued for 55 days (fig 1). All 
four drugs were changed from the intravenous to the oral route 
when diet was resumed. Doses of intravenous prostaglandin were 
0·4 to 1·0 ~gjkg per hour PGE, and for the oral form were 6 ll8/kg 
per day PGE, (misoprostil). From days 12 to 21, prednisone was 
stopped except for a 1 g bolus of methylprednisolone. 
Postoperative investigations 
Biochemical studies-Standard liver and renaI function tests 
were repeated daily. In addition, the arterial ketone body ratio, 
which estimates hepatic mitochondrial integrity and liver energy 
charge," was monitored daily for the first 30 days. Attention was 
paid especially to tests whose normal ranges were strikingly 
divergent in the baboon and human: protein electrophoresis, 
albumin, alkaline phosphatase, uric acid, and cholesterol. 
Immunological studies-Complanent-dependent cytotoxicity 
was measured in pretransplant and post-transplant patient serum 
samples that were tested against lymphOcyteS from either the donor 
baboon or a panel of third-party human donors. Serum samples 
were tested with and without dithiothreitol (OTT) treaanent, 
which inactivates IgM, thus permitting detection of IgG.15 Donor 
Days 
Fig 1-Clinical course after baboon liver transplant. 
SM. Solumedrol (methylprednisolone); PGE. prostaglandin E; Bx. 
biopsy; AST. aspanale aminotransferase; ALT. alamne amInotransferase; 
Alk Ph. alkaline phosphatase. 
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TABLE II-POST-TRANSPLANT INFECTIOUS COMPLICATIONS 
Postoperative 
day Infection Organism Treatment 
7 Wound infection Staphylococcus Vanoomycin and 
and bacteraemia debridement 
27 Bacteraenua Staphylococcus Vanoomycin 
29 Oesophagitis Candida a1bicans Amphotericin 
30 Viraemia Cytomegalovirus Ganciclovir 
42 Oesophagitis and Cytomegalovirus Ganciclovir 
viraemia 
55 Bacteraemia Enteroaxx:us Vanoomycin 
faecalis 
56 Bac:teracmia Staphylococcus Vanoomycin 
61 Sepsis Preswned Amikacin and 
cholangitis after imipenem/cilas . 
pcra1taneous 
tranShepatic 
cholangiogram 
68 Sputum Aspergillus lIavus Amphotericin 
70 Dcarh Disseminated 
aspergillus (at 
necropsy) 
baboon lymphocytes were isolated at the time of transplantation 
from lymph nodes and spleen, and were cryopreserved in tissue 
culture media supplemented with 20% pooled baboon sera. 
Dilutions of patient sera were made to 1 in 512 for pre-transplant 
samples and 1 in 32 for post-transplant sera. Rabbit complement for 
crossmatch testing was absorbed with baboon red cells. Pooled 
human sera and pooled baboon sera were used for positive and 
negative crossmatch conaols, respectively. Daily samples were 
collected from the patient, batched and tested every three days in the 
first month post-transplant. 
For mitogen response assays, peripheral blood lymphocytes from 
heparinised blood samples of the xenograft recipient were isolated 
by a Ficoll-Hypaque gradient and were resuspended at a 
ooncenttation of 5 x 10" cells per well for 72 h at 37·C with either 
ooncanavalin A (ConA) (4 ~/mlF or phytohaemagglutinin (pHA) 
(10 ~/mlFK 
Unidirectional mixed lymphocyte reaction (MLR) cultures were 
set up with 5 x 10" responder (patient) and 5 x 10" irradiated 
baboon lymphocytes (donor) or 5 x 10" irradiated third-party 
human lymphocytes (allooontrol) in 200 iii tissue culture medium 
for 6 days. Cryopreserved baboon lymphocytes were thawed and 
prepared in 5% baboon serum. 
Total oomplement activity (CH100) was quantitated by an 
agarose-gel method that measured lysis by test sera of sheep red 
blood cells (Kallestad, Austin, Texas)"" Antigen-antibody 
oomplexes were detected on stained agarose gels after routine zone 
electrophoresis." 
Chimerism was determined by polymerase chain reaction 
amplification of the baboon chorionic gonadoaopin gene. Primers 
(CCACCCCATGGTCTCCGTIC and GAACGGGGTGCC-
TGCTCC) were selected from the middle exon of the beta subunit 
of baboon chorionic gonadotrophin such that they did not amplify 
the oorresponding human sequence. 18 The sensitivity and 
specificity of the method was determined by amplification of 
baboon DNA serially diluted with human DNA. The quantity of 
baboon DNA present in the various tissues was estimated from an 
autoradiogram of a Southern blot of the PCR products after 
hybridisation with a radiolabelied probe prepared from the baboon 
gene. 
Histopathological studies-Wedge or needle biopsy specimens 
of the xenograft liver were obtained at operation and on days 12, 24, 
55, and 64 post-transplantation. One part was frozen in Optimum 
Cold Temperature for immwlOfluorescent studies (IF) and the 
remainder was fixed in formalin. Anti-baboon antibodies were 
sought by indirect IF rrticroscopy (tissue crossmatch) with the 
recipient'S serum as the primary antibody, followed by fluorescein-
labelled anti-human IgG and IgM as the secondary 
immunoreactants. Frozen tissue was also studied with direct IF 
using anti-human IgG, 19A, IgM, Clq, 0, C4, fibrinogen, 
alpha-2-macroglobulin, and albumin. 
Fig 2-Cholangiogram on day 81. 
The ducts are much larger than at the time of transplantation and the 
sharp cut off of a major duct (arrow) was probably because of sludge 
found at necropsy. 
Phenotypic analyses of the cellular infiIttates with routine 
indirect avidin-biotin oomplex technique were performed on 
paraffin-embedded tissues with antibodies directed at T (L60, 
UCHL-l, OPD4 [CD4j), B (L26, IgG, IgM), and NK (Leu-7) 
celis, and rnacropbages and neutrophils (lysozyme). We adopted the 
same technique to monitor HBV infection (anti-HBsAg and 
anti-HBcAg) and proliferative activity (anti-proliferating cell 
nuclear antigen). 
Results 
Clinical course 
After transplantation, our patient, who had lapsed into 
stage 3 coma preoperatively, woke promptly and was 
extubated after 17 h. He was eating and walking within 5 
days. For the first two postoperative weeks, hwnan albumin 
50-75 g/day was given intravenously. Albumin was then 
administered only to cover losses from dialysis procedures 
or during plasmapheresis for haemoglobinaemia during the 
tenninal phase of his postoperative course. The liver was 
600 g at the time of transplantation and regenerated to a 
computed tomographic (CT) scan estimated size of 1074 g 
after one week and 1555 g by day 24. Although he was 
released from intensive care after one month, he developed 
several infections (table 11) that necessitated treatment with 
nephrotoxic antibodies. The most disabling of these was 
mixed CMV and candida oesophagi tis and duodenitis, 
which were suspected to be the cause of recurrent 
gastrointestinal haemorrhages from days 27-39 and which 
required 14 units of transfused blood. Staphylococcus aureus 
was cultured from the blood on postoperative days 6, 26, and 
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Fig 3-Protein electrophoresis of normal humen. baboon 
donor. and patient serum. 
C3. complement; Tf. transferrin. 
55; Enterococcus faecalis was fOWld cultured on day 55. On 
day 65, aspergillus was cultured from a tracheal aspirate. 
Other complications included renal failure and dialysis 
dependence beginning on day 21, which probably resulted 
from multiple drug toxicity (FK 506, amphotericin, 
ganciclovir, and possibly vancomycin) and a right 
haemothorax from a liver biopsy on day 24. Despite these 
difficulties, the patient was afebrile and otherwise well Wltil 
day 55 when he was readmitted to intensive care after 
jaundice recurred. Angiography on day 59 showed normal 
hepatic vascular anatomy; a ttanshepatic cholangiogram on 
day 61 was read as normal (fig 2). I h after cholangiography, 
he became hypotensive with rigors; he required intubation. 
There was evidence of disseminated intravascular 
coagulation and haemolysis with a fall in platelet COWlt from 
115000 to 29000 x 1000/L, an increased free plasma 
haemoglobin of 87'5 mg/dl (normal < 3'0), Wldetectable 
haptoglobin, and a rise in bilirubin from 212 mmoi/L to 
851'6 mmol/L during the next 48 h. 
From days 65 to 70, the patient had 5 plasmaphereses that 
reduced serwn bilirubin. On day 70, while being weaned 
from the ventilator, there was a sudden loss of higher 
nervous system function. A cr scan showed a massive 
subarachnoid haemorrhage and 6 h later he was declared 
brain dead. 
Biochemical studies 
The arterial ketone body ratio rose from 0·3 (low) during 
woWld closure to > 1·0 at 3 days and beyond, indicating 
excellent hepatic energy charge. Tests of liver injury 
(aminotransferase concentrations) were increased to a 
maximum of 250 lUlL during the first few days post-
transplantation and after the cholangiogram. Bilirubin 
concentrations were also nonna! throughout most of the 
post -operative course (fig 1); however, alkaline phosphatase 
was increased from the end of the the first week onward. 
Prothrombin time and other indices of hepatic synthetic 
function were similar to those measured preoperatively. The 
relative hypoalbuminaemia was well tolerated by the 
patient; he had no evidence of fluid retention at any time. 
Serwn protein electrophoresis in the recipient showed that 
other protein fractions of hepatic origin promptly reverted 
to those of the baboon (fig 3). Plasma ammonia 
concentration was 139 mmol/L preoperatively, and fell to 
below 50 mmol/L after the first week (nonna! < 50). Serwn 
uric acid (normally < 30 mmol/L in the baboon) fell from 
481·8 mmol/L in our patient into the expected baboon 
range. A similar but less dramatic transition was seen with 
serwn cholesterol (table I). 
Immunological and viral studies 
Preoperatively the recipient's serwn samples had 
complement-dependent lymphotoxic antibody activity 
against 73% to 89% of a 45 cell panel ofHLA-typed donors 
and against lymphocytes from 7 different baboons including 
the eventual donor. After DTT treatment, the 73-89% 
panel-reactive antibody before transplantation became 0%, 
and the patient's positive serwn crossmatch with all 7 
baboon donors became weak-positive. All serum samples 
post-transplantation were crossmatch negative after DTT 
treatment. Daily serwn samples tested for donor-specific 
crossmatch without DTT showed minimum change in 
titres ranging from 1 in 8 to 1 in 16 throughout the first 
month post-transplant. 
The total white blood cell COWlt preoperatively was 
13 x IO"/L with 6'2 x 10"/L lymphocytes (28% CD4,58% 
CD8; ratio 0'48). After transplantation, the total number of 
white blood cells remained constant but the number of 
lymphocytes fell to below 0·6 x 109/L. Pretransplantation, 
he had a normal immWle response to several stimuli, 
including mitogens (PHA and Con A), alloantigens, and 
other donor-baboon lymphocytes (table III). 
Postoperatively, our patient's lymphocytes failed to respond 
to allo or xeno antigens and the only significant proliferation 
took place with PHA. 
The total complement (CHlOO) fell from nonna! 
preoperatively to below the limit of detection ( < 21 U /mL) 
for the first 8 postoperative days during which circulating 
antigen-antibody complexes were present (table IV). 
Thereafter, the CHIOO ranged from slightly depressed to 
normal at the same time as complexes were detectable. The 
results were similar to those observed by Manez et a116 in 
successfully treated recipients of lymphocytotoxic-
crossmatch-positive allografts_ With the return of CHIOO, 
C3, which is thought to be synthesised mainly in the liver, 19 
was slightly depressed while C4 and C5 were nonna!. C4 is 
also thought to be mainly hepatic in origin.:ZO 
TABLE 11l-IN-VITRO TESTS OF IMMUNE REACTIVITY 
WBC (x 10"/L) Proliferative responses (net cpm) 
Time (wks) Total Lymphocytes PHA Con A Xeno MLR AlloMLR 
~ve 13 6·2 90,263 13.371 44.794 74,290 
1 10·5 0·5 8,591 436 112 413 
2 5·9 0·3 384 90 100 250 
4 10'2 0·4 16.788 92 121 62 
6 6·9 0·3 1,963 81 59 48 
8 H 0·6 37.945 4.606 448 156 
9 8·4 0·9 1,248 90 120 127 
Cpm. counts per minute. 
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TABLE IV-TOTAL SERUM COMPLEMENT (CH100). COMPLEMENT 
COMPONENTS (U/mL). AND IMMUNE COMPLEXES (IC) 
Days CH100 C3 C4 C5 
postop (>60) (B3-177) 15-45) (6-20) IC 
1 <21 .. .. .. + 
2 <21 .. .. .. + 
4 <21 .. .. .. + 
6 <21 .. .. .. 
8 <21 .. .. .. + 
9 <21 .. .. .. -
11 21 .. .. .. -
14 43 .. .. .. -
17 55 64 17 20 -
23 66 59 15 17 -
26 61 51 15 11 + (low) 
28 44 40 13 14 -
33 55 58 14 15 + (low) 
64 55 .. .. .. -
Baboon DNA was found in the patient's hean, lung, 
kidney, and two lymph nodes obtained at necropsy (fig 4). 
The blood samples collected during life also were positive. 
In some tissues, baboon and human DNA were found in a 
ra~o ofl in 1000 whereas in others, such as lymph nodes, the 
raoo was close to 1 in 10 000 (fig 4). 
HIV status did not change significantly after 
transplantation. Cell dilution method for quantification of 
HIV -infected cells showed 66 infected cells per million 
peripheral blood mononuclear cells (PBMC) on days 2 and 
17, with 16 infected cells per million PBMC on post-
transplant days 31 and 59 (courtesy of Dr Phalguni GuPta, 
Graduate School of Public Health, University of 
Pittsburgh). 
Pathological studies 
Tissue crossmatch of the xenograft before 
revascularisation with pretransplant recipient serum 
showed a diffuse non-specific staining pattern with anti-
IgG. Anti-lgM revealed faint portal vein staining, focal 
sinusoidal cell positivity, and distinct nuclear staining 
consistent with the preformed antibody detected on 
conventional crossmatch. 
The 4 h post-perfusion biopsy revealed Kupffer cell 
hypertrophy, sinusoidal neutrophilia, and small platelet 
aggregates in the sinusoids and portal and hepatic veins, 
without hepatocyte necrosis or inflammatory or necrotising 
vasculitis. Direct IF showed diffuse sinusoidal fibrinogen 
(IgG> 19A > IgM) with linear-granular sinusoidal Clq, 
LI 
Human/Blboo" 
HE LU KI LN LN HU 1()6 loS 10' 1()3 
I 2 
.. 
BL 
• 
Fig 4-PCR amplification of baboon-specific DNA from 
recipient tiuua. 
Lane LI is the PCR product from baboon liver and contains only 1 % of 
PCR .reaction to avoid overwhelming the other lanes. HE. hean; LU. lung; 
Kt kidney. LN1 and LN2. lymph nodes 1 and 2. For semiquantitation. 
either human (H U) or baboon DNA was serially diluted into human DNA 
at the indicated ratios and tested. showing a baboon DNA concentration 
of approximately 0·1% in most specimens. Blood (BL) was obtained 35 
days post-transplantation and all other samples were taken at necropsy 
(day 70). 
Fig 6-Histopathological studies. 
Upper figure: 12 day&-ponal tract with most severa rejection ( x 100). 
Lower figure: 65 days--<lisruption of epithelium of septal bile duct with 
no evidence of rejection (x 400). 
Kupffer cell localisation of C3, and scant C4. Focal mild 
portal vein and hepatic arterial endothelial IgM deposits also 
were present. The diagnosis of mild humoral damage was 
made. 
A wedge biopsy taken on day 12 showed Kupffer cell 
hypertrophy, mild centrilobular hepatocyte swelling, and 
~olestasis with a mild mononuclear portal and perivenular 
infiltrate (fig 5 upper). The infiltrate was comprised 
predominantly of T and NK cells, which were detected 
inside the basement membrane of a few small septal bile 
ducts and in the sinusoids. Subset analysis showed that 
about a third of portal T cells were CD4 +, with the 
remainder presumably CD8 + . Inflammatory or 
necrotising arteritis was not seen. Direct IF fIndings were 
qualitatively ~imi1ar to those of the post-perfusion biopsy, 
but were less Intense. No HBV antigens were detected and a 
PCNA labeling index in hepatocytes approached 35-40%. 
Diagnoses of regeneration and of mild cellular rejection 
(with a small humoral component) were made. 
The single needle core of tissues obtained on day 24 was 
unremarkable except for mild cholestasis and Kupffer cell 
hypertrophy. Direct IF revealed striking decreases in all 
immunoglobulins and no detectable complement 
components. The diagnosis was mild cholestasis. The 
fourth liver biopsy on day 55 after an increase in total serum 
bilirubin to 78'7 mmol/L was also unremarkable except for 
Kupffer cell hypertrophy and a slight increase in sinusoidal 
mononuclear cells, with little or no portal or perivenular 
infiltrate and no evidence of inflammatory or necrotising 
vasculitis. Direct IF examination revealed a slight increase 
in sinusoidal immunoglobulin deposits with scant but 
detectable Clq. A diagnosis was made of sinusoidal 
reactivity with little evidence of rejection; minimum 
cholestasis was noted. 
The fifth (wedge) biopsy was obtained intraoperatively on 
day 65,3 days after the transhepatic cholangiogram which 
had led to a septic crisis. Cholestasis was conspicuous with 
70 
several bile infarcts, and focal mural necrosis of occasional 
septal bile ducts (fig 5 lower). Fewer than half the portal 
triads contained a mild mononuclear infiltrate, qualitatively 
similar in phenotypic composition to that seen earlier. More 
than 30% of bile ducts contained more T cells than NK cells 
inside the basement membrane, and these were associated 
with duct epithelial damage. There was no evidence of 
inflammatory, necrotising, or obliterative arteritis or 
coagulative vascular necrosis. Direct IF showed a sinusoidal 
panern similar to that seen in the post-reperfusion sample, 
but with no arterial or vein deposits, consistent with the lack 
of vasculitis on light microscopy. Stains for HBV antigens 
were negative. A diagnosis of mild rejection, cholestasis, and 
bile infarcts, consistent with large duct obstruction, was 
made. 
Endoscopic biopsy specimens of either the oesophagus, 
stomach, and/or duodenwn were obtained on days 29, 30, 
39, 43, and 55 because of complaints of anorexia and 
abdominal pain. Candida and severe cytomegalovirus 
oesophagitis were diagnosed on days 29 and 39, respectively. 
Necropsy 
The cause of death was diffuse subarachnoid 
haemorrhage and left uncul brainstem herniation, 
secondary to invasive aspergillosis in multiple sites in the left 
brain; haemorrhagic aspergillus lesions were also found in 
the left and right lungs, and left kidney. Other findings in the 
kidney were mild arterial nephrosclerosis, glomerular 
lobular accentuation, mesangial expansion and 
hypercellularity, and acute tubular necrosis. There was 
residual CMV oesophagitis and gastritis. 
The hepatic arterial, portal venous, and vena caval 
anastomoses were patent. The biliary anastomosis was intact 
and patent, but the bileduct mucosa was dusky. Biliary 
sludge occupied the entire intrahepatic biliary tree, from the 
first-order branches through the extrahepatic ducts. 
Otemical studies of the material were characteristic of 
pigment sludge that, on histopathological examination, 
consisted of a large component (80%) of cellular debris. 
This finding was similar to that seen in past allografts with 
biliary stasis or obstruction. Multiple bile infarcts were 
present throughout the liver. There was no gross or 
histopathological evidence of inflammatory or obliterative 
arteriopathy of the deep hilar, peripheral, and peri-
anastomotic graft arteries. There was no significant portal 
infiltrate in any oithe multiple samples. 
Discussion 
We have reported previously that the incidence and 
management of liver allograft rejection were not 
substantially different in HIV-positive liver recipients than 
in those testing HIV negative.Z1 Because our patient was 
immunocompetent before transplantation, the 
immunosuppression postoperatively was thought to be 
iatrogenic, not due to HIV. We believe that the four drug 
immunosuppressive regimen ofFK 506, prednisone, PGE, 
and cyclophosphamide was effective in preventing both 
cellular rejection and the occlusive endotheliolitis attributed 
to antibody-mediated rejection in previously described 
baboon-to-human xenografts.O.5 
The fatal outcome followed unrecognised biliary stasis 
with consequent diffuse damage of intrahepatic ducts, 
sludge formation, and bacterial infection. The raised 
alkaline phosphatase and jaundice were ascribed to rejection 
and treated as such despite the lack of histopathological 
,.; 
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evidence for this diagnosis. Similar technical and 
management difficulties of the biliary system, which 
ultimately proved correctable impeded early development 
of liver allotransplantation more than any other single 
factor.zz It is likely that the biliary stasis found in our hepatic 
xenograft is preventable by stenting the biliary anastomosis 
with an exteriorised catheter that can also be used for 
cholangiography or irrigation postoperatively. However, we 
cannot exclude duct-specific immunologic injury or even 
chemical injury from a drug such as cyclophosphamide. 
Our acknowledgement that failure in this case was 
probably technical permits an encouraging interpretation of 
other observations in this patient. The most important 
modification of immunosuppression must be restriction of 
cyclophosphamide to the perioperative period, as is 
necessary for prevention of antibody-mediated rejection of 
hamster organs transplanted to rats.6 ,7 Because of the fear of 
organ rejection in our patient, this drug was continued for 
nearly two months with probable over-immunosuppression. 
However, the preformed lymphocytotoxic IgM antibodies 
present preoperatively in our patient's serwn did not 
increase after transplantation, and no circulating cytotoxic 
IgG antibodies were ever measurable postoperatively. 
Diffuse IgM and IgG antibodies demonstrated in the 
xenograft biopsy sample by immunofluorescence at 12 days 
had largely disappeared by 24 days. 
The liver xenograft is thought to have immunological 
advantages compared with other potentially transplantable 
organs, including greater resistance to humoral rejection and 
an unusual ability to take part in the induction of its own 
acceptance. Z3 These advantages are explained by a high 
density of potentially migratory leukocytes of bone-marrow 
origin, including Kupffer cells, which are crucial to the 
development of systemic reCIpIent chimerism.zo.zs 
Circulating baboon DNA was demonstrated by polymerase 
chain reaction after 35 days in our xenograft recipient, and at 
necropsy chimerism was confirmed in all tissues and organs 
tested. This fmding after allo or xeno transplantation is 
construed as the flI'St step toward chronic acceptance and 
ultimately donor-specific tolerance.zo 
An additional question largely answered by this single 
case is whether production by a liver xenograft of donor 
phenotype proteins and other synthetic products would 
result in a lethal incompatibility of metabolism in the 
recipient. The fall in serwn uric acid and cholesterol 
concentration postoperatively to the low values that are 
normal for the baboon was an especially dramatic 
demonstration of the recreation by the xenograft of its own 
chemical environment and with no apparent adverse effects. 
As expected, the serum protein panern of the recipient 
rapidly approached that of the baboon, including proteins 
involved in immune reactions or blood coagulation. The low 
serum albumin produced by the xenograft was well 
tolerated. These observations and those in rat recipients of 
hamster liversZ6 suggest that donor-specific products of 
hepatic synthesis will not preclude liver xenotransplantation 
from a concordant species donor. It was also noteworthy 
that liver regeneration of the originally small xenograft took 
place at a similar time course described for the human liver. 
Death at 70 days was too soon to allow a conclusion that 
the transplanted baboon liver could successfully resist 
infection with HBV. However, there was no evidence of the 
HBsAg or HBcAg in the transplant at necropsy. Infection of 
allografts with HBV has been recorded frequently during 
this time.28 Since the baboon cannot be easily infected with 
HIV (if at all),29 longer observation might have provided 
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data about HIV status of the chimeric baboon 
lymphodendritic cells of monocyte/macrophage lineage, 
which are thought to account for the post-transplant 
chimerism that is invariably found after successful hepatic 
allotransplantation. Evidence of chimerism was widespread 
in the xenograft recipient'S organs. The crucial question will 
be whether HIV -resistant chimeric xenogeneic cells would 
have a survival advantage over infected autologous cells of 
the same lineage, and whether this could ultimately 
influence the course of HIV infection favourably. An 
additional question raised by the recent observation that FK 
506 and cyclosporin interfere with HIV production and 
selectively inhibit growth of infected cells30 is whether 
chronic immunosuppression with these drugs could have an 
antiviral effect. The long survival of several HIV-infected 
liver recipients is compatible with this possibility.31 
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From The Lancet 
Ocean travel 
Life at the end of the nineteenth century is so eager and full of 
struggle, competition is so keen, the reward of successful effon so 
great, that most of us in every station neglect those precautions and 
habits upon which continued health chiefly depends. Prolonged 
and anxious intellectual labour, irregular hours, wann and ill-
ventilated rooms, insufficient sleep and exercise, strain the nervous 
system, beget indigestion and innumerable physical evils. The 
physiological and prophylactic remedies of out-door exercise, rest, 
diet, rational amusement, which do so much to keep us in health, are 
not so generally utilised as their inestimable value deserves. 
Accordingly we approach the summer season jaded, worn, with 
nerves unstrung, appetite feeble, digestion faulty, sleep restless and 
insufficient. Rest is urgently demanded; the brain needs to lie fallow 
for a time that it may recuperate after its strenuous energy. Among 
the many means to which we may reson for restoration of physical 
and intellectual force I would unhesitatingly assign a high, perhaps 
the highest, place to ocean travel .... Life at sea is sufficiently full of 
incident to avoid the reproach of dullness. One meets with old 
friends or fonns new acquaintances and a pleasant, leisurely 
intercourse pennits the days to glide by without weariness. The sea 
air, always in circulation and charged with ozone, invigorates the 
exhausted system. Movement is not restrained. We feel the ship 
beneath us forging its way through the water, the deck affords us an 
ample promenade, the heaving surface of the ocean a picture full of 
chann. The pure salt breeze fans our cheeks, the porpoise or the 
shark claims a share of our attention, and as We traverse the ocean 
highway we meet other steamers sending up their clouds of smoke 
or sailing vessels with canvas spread to catch the wind. 
(July 23, 1892) 
